Lloyd Mack
Overview
Explore the profile of Lloyd Mack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oravec N, Mack L, Hallock D, McClurg C, Quan M
Am J Surg
. 2025 Jan;
242:116202.
PMID: 39854927
Introduction: There is a paucity of data to support surveillance protocols for localized, low-grade appendiceal mucinous neoplasms (LAMNs) after resection. Methods: A search strategy was developed to identify postoperative surveillance...
2.
Stockley C, Bouchard-Fortier A, Mateshaytis J, Taqi K, Mack L, Nelson G, et al.
J Surg Oncol
. 2024 Oct;
PMID: 39359111
Background And Objectives: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) can be associated with prolonged hospital stays. A novel Enhanced Recovery After Surgery (ERAS) based on ERAS Society guidelines was...
3.
Taqi K, Lee J, Hurton S, Stockley C, Mack L, Rivard J, et al.
Curr Oncol
. 2024 Jul;
31(7):3657-3668.
PMID: 39057141
Background: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a major treatment of colorectal peritoneal carcinomatosis (CPC). The aim was to determine the disease-free survival (DFS) and overall...
4.
Vallance P, Mack L, Bouchard-Fortier A, Jost E
Curr Oncol
. 2024 Feb;
31(2):872-884.
PMID: 38392059
Surgical management of gastric adenocarcinoma can have a drastic impact on a patient's quality of life (QoL). There is high variability among surgeons' preferences for the type of resection and...
5.
Briere R, Emond M, Benhamed A, Blanchard P, Golbon B, Shellenberger J, et al.
Can J Surg
. 2024 Jan;
66(6 Suppl 1):S54-S136.
PMID: 38173057
No abstract available.
6.
Deban M, Taqi K, Knapp G, Soucisse M, Curry M, Sideris L, et al.
J Surg Oncol
. 2023 May;
128(4):595-603.
PMID: 37249154
Introduction: Peritoneal mesothelioma (PM) is a rare malignancy originating from the peritoneal lining. Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) is the standard-of-care for patients with isolated PM. Due...
7.
Choi K, Mack L, Caragea M, Monument M, Puloski S, Bouchard-Fortier A
Am J Surg
. 2022 Apr;
224(2):747-750.
PMID: 35397923
Introduction: Well-differentiated liposarcomas (WDLS) are low-grade lipomatous tumors with low malignant potential. Previous review identified controversy on whether upfront wide resection is necessary when they occur on the trunk or...
8.
Nostedt J, Sample C, Ghosh S, Turner S, Mack L, McCall M, et al.
Can J Surg
. 2022 Mar;
65(2):E221-E227.
PMID: 35318242
Background: Despite guidelines recommending diagnostic laparoscopy in patients with gastric cancer, implementation is low. We aimed to explore trends in the use of laparoscopy for staging of gastric cancer in...
9.
Shariff F, Bischof D, Govindarajan A, Prince R, Burkes R, Haase E, et al.
Curr Oncol
. 2021 Mar;
28(1):40-51.
PMID: 33704173
The COVID-19 pandemic has put enormous pressure on hospital resources, and has affected all aspects of patient care. As operative volumes decrease, cancer surgeries must be triaged and prioritized with...
10.
Hubner M, Kusamura S, Villeneuve L, Al-Niaimi A, Alyami M, Balonov K, et al.
Eur J Surg Oncol
. 2020 Sep;
46(12):2292-2310.
PMID: 32873454
Background: Enhanced recovery after surgery (ERAS) pathways have been shown to considerably reduce complications, length of stay and costs after most of surgical procedures by standardised application of best evidence-based...